[1]
“In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii clinical isolates: a single center experience. ”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023043, Jun. 2023, doi: 10.4084/MJHID.2023.043.